Fidelis Capital Partners, LLC Instil Bio, Inc. Transaction History

Fidelis Capital Partners, LLC

  • $702 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
SELL
$0.4 - $0.63 $792 - $1,247
-1,980 Reduced 14.92%
11,288 $4.83 Million
Q2 2023

Aug 10, 2023
BUY
$0.51 - $0.67 $6,766 - $8,889
13,268 New
13,268 $7.31 Million

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $8.8B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Fidelis Capital Partners, LLC Portfolio

Follow Fidelis Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelis Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fidelis Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email